Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care

Empax Center brings significant expertise in clinical trial execution for mental health and neurological conditions Psyence Biomed on track to begin recruitment this quarter, and to announce Adjustm… [+8290 chars]

Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute
Cancer Immunotherapy Market Research Report 2025-2029: Curing Cancer is Generating Enormous New Markets - How Big Are They? Where is the Opportunity?
Briefing by Deputy Chief of the Nuclear, Chemical, and Biological Protection Troops of the Russian Armed Forces Major General Aleksei Rtishchev

Gulf Resources Holds 2024 Annual Meeting of Stockholders
Meet 10 of the New Plant and Animal Species Identified in 2024